New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 8, 2013
13:56 EDTUTHRUnited Therapeutics price target raised to $75 from $65 at Argus
Argus increased its price target on United Therapeutics after the company reported higher than expected Q4 EPS. The firm continues to believe that the company will generate strong long-term growth, and it maintains a Buy rating.
News For UTHR From The Last 14 Days
Check below for free stories on UTHR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
07:17 EDTUTHRUnited Therapeutics price target raised to $150 from $120 at H.C. Wainwright
H.C. Wainwright raised its price target for United Therapeutics shares to $150 citing strong sales and positive prospects following the company's Q2 results. The firm reiterates a Buy rating on the stock.
July 29, 2014
06:07 EDTUTHRUnited Therapeutics reports Q2 EPS $2.30, consensus $1.75
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use